The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study
Open accessAbstract
Osteosarcoma is the most common primary malignant tumor of bone, the long-term survival of which has stagnated in the past several decades. Celastrol, a triterpene from traditional Chinese medicine, has been proved to possess potent anti-tumor effect on various cancers. However, the effect of celastrol on human osteosarcoma and the underlying mechanisms remains to be elucidated. We reported here that celastrol could inhibit cell proliferation by causing G2/M phase arrest. Exposure to celastrol resulted in the activation of caspase-3, -8, and -9, indicating that celastrol induced apoptosis through both extrinsic and intrinsic pathways. Autophagy occurred in celastrol-treated cells as evidenced by formation of autophagosome and accumulation of LC3B-II. The celastrol-induced cell death was remarkably restored by the combination of autophagy and apoptosis inhibitors. Furthermore, inhibition of apoptosis enhanced autophagy while suppression of autophagy diminished apoptosis. Celastrol also induced JNK activation and ROS generation. The JNK inhibitor significantly attenuated celastrol-triggered apoptosis and autophagy while ROS scavenger could completely reverse them. The ROS scavenger also prevented G2/M phase arrest and phosphorylation of JNK. Importantly, we found that celastrol had the similar effects on primary osteosarcoma cells. Finally, in vivo, celastrol suppressed tumor growth in the mouse xenograft model. Taken together, our results revealed that celastrol caused G2/M phase arrest, induced apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells. Celastrol is therefore a promising candidate for development of antitumor drugs targeting osteosarcoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,831
Role of reactive oxygen species (ROS) in apoptosis induction
Simon, H.-U., Haj-Yehia, A., & Levi-Schaffer, F. (2000) · Apoptosis · doi:10.1023/a:1009616228304 · Cited by 2,774
The stress-activated protein kinase subfamily of c-Jun kinases
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., & Woodgett, J. R. (1994) · Nature · doi:10.1038/369156a0 · Cited by 2,596
ROS stress in cancer cells and therapeutic implications
Pelicano, H., Carney, D., & Huang, P. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.01.004 · Cited by 2,006
Kamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Endonuclease G is an apoptotic DNase when released from mitochondria
Li, L. Y., Luo, X., & Wang, X. (2001) · Nature · doi:10.1038/35083620 · Cited by 1,787
Crosstalk between apoptosis.; necrosis and autophagy
Nikoletopoulou, V., Markaki, M., Palikaras, K., & Tavernarakis, N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.001 · Cited by 1,366 · cited 1×
“Considerable evidence has delineated the complex interplay between apoptosis and autophagy, which can cooperate, antagonize or assist each other.(20,47) In our study, z-VAD-fmk”
BackgroundPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Life and death partners: apoptosis, autophagy and the cross-talk between them
Eisenberg-Lerner, A., Bialik, S., Simon, H.-U., & Kimchi, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.33 · Cited by 1,183
Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation
Sauer, H., Wartenberg, M., & Hescheler, J. (2001) · Cellular Physiology and Biochemistry · doi:10.1159/000047804 · Cited by 1,118
Mitochondrial reactive oxygen species in cell death signaling
Fleury, C., Mignotte, B., & Vayssière, J.-L. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01369-x · Cited by 1,068
Regulation of p53 in response to DNA damage
Lakin, N. D., & Jackson, S. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203015 · Cited by 987
Reactive Oxygen Species: A Breath of Life or Death?
Fruehauf, J. P., & Meyskens, F. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2082 · Cited by 915
The machinery of programmed cell death
Zimmermann, K. C., Bonzon, C., & Green, D. R. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00159-0 · Cited by 833
Ways of dying: multiple pathways to apoptosis
Adams, J. M. (2003) · Genes & Development · doi:10.1101/gad.1126903 · Cited by 776
Another way to die: autophagic programmed cell death
Tsujimoto, Y., & Shimizu, S. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401777 · Cited by 754
Shen, H.-M., & Liu, Z.-G. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.056 · Cited by 629
Yang, H., Chen, D., Cui, Q. C., Yuan, X., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4529 · Cited by 586
Caspase-8 and Bid: Caught in the act between death receptors and mitochondria
Kantari, C., & Walczak, H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.026 · Cited by 502
Chen, Y., McMillan-Ward, E., Kong, J., Israels, S. J., & Gibson, S. B. (2007) · Journal of Cell Science · doi:10.1242/jcs.011163 · Cited by 443
Gozuacik, D., & Kimchi, A. (2007) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)78006-1 · Cited by 437
G2 checkpoint abrogators as anticancer drugs
Kawabe, T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.513.3.4 · Cited by 377
Allison, A. C., Cacabelos, R., Lombardi, V. R. M., Álvarez, X. A., & Vigo, C. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00192-0 · Cited by 376
Singh, S. V., Herman-Antosiewicz, A., Singh, A. V., Lew, K. L., Srivastava, S. K., Kamath, R., Brown, K. D., Zhang, L., & Baskaran, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313538200 · Cited by 347
Cell-cycle dysregulation and anticancer therapy
Stewart, Z. A., Westfall, M. D., & Pietenpol, J. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00026-9 · Cited by 344
Sethi, G., Ahn, K. S., Pandey, M. K., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-10-050807 · Cited by 336
Apoptosis and non-apoptotic deaths in cancer development and treatment response
de Bruin, E. C., & Medema, J. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.001 · Cited by 279
Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
Ando, K., Heymann, M.-F., Stresing, V., Mori, K., Rédini, F., & Heymann, D. (2013) · Cancers · doi:10.3390/cancers5020591 · Cited by 234
Wang, W., Feng, L., Yue, Q., Wu, W., Guan, S., Jiang, B., Yang, M., Liu, X., & Guo, D. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22956 · Cited by 205
Apoptosis-inducing factor: A matter of neuron life and death
Krantic, S., Mechawar, N., Reix, S., & Quirion, R. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.12.002 · Cited by 192
Kannaiyan, R., Manu, K. A., Chen, L., Li, F., Rajendran, P., Subramaniam, A., Lam, P., Kumar, A. P., & Sethi, G. (2011) · Apoptosis · doi:10.1007/s10495-011-0629-6 · Cited by 170
Xavier, L. L., Viola, G. G., Ferraz, A. C., Da Cunha, C., Deonizio, J. M. D., Netto, C. A., & Achaval, M. (2005) · Brain Research Protocols · doi:10.1016/j.brainresprot.2005.10.002 · Cited by 166
Rajendran, P., Li, F., Shanmugam, M. K., Kannaiyan, R., Goh, J. N., Wong, K. F., Wang, W., Khin, E., Tergaonkar, V., Kumar, A. P., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0420 · Cited by 158
Tao, X., Cush, J. J., Garret, M., & Lipsky, P. E. (2001) · PubMed · Cited by 142
Lee, J.-H., Won, Y., Park, K. H., Lee, M., Tachibana, H., Yamada, K., & Seo, K. (2012) · APOPTOSIS · doi:10.1007/s10495-012-0767-5 · Cited by 127
Osteosarcoma Multidisciplinary Approach to the Management from the Pathologist’s Perspective
Raymond, A. K., & Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_4 · Cited by 125
Huang, Y., Zhou, Y., Fan, Y., & Zhou, D. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.043 · Cited by 122
Deng, Y., Shi, J., Liu, J., & Qu, Q. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.04.005 · Cited by 106
Peng, B., Xu, L., Cao, F., Wei, T., Yang, C., Uzan, G., & Zhang, D. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-79 · Cited by 104
Knowles, L. M., & Milner, J. A. (2000) · Carcinogenesis · doi:10.1093/carcin/21.6.1129 · Cited by 102
Yu, X., Tao, W., Jiang, F., Li, C., Lin, J., & Liu, C. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.75 · Cited by 86
Avisetti, D. R., Babu, K. S., & Kalivendi, S. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087050 · Cited by 69
SAPK/JNK regulates cdc2/cyclin B kinase through phosphorylation and inhibition of cdc25c
Goss, V. L., Cross, J. V., Ma, K., Qian, Y., Mola, P. W., & Templeton, D. J. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00009-3 · Cited by 46
Zhang, R., Wang, Y., Li, J., Jin, H., Song, S., & Huang, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.513960 · Cited by 44
Lin, H., Liu, X. Y., Subramanian, B., Nakeff, A., Valeriote, F. A., & Chen, B. D. (2001) · International Journal of Cancer · doi:10.1002/ijc.1570 · Cited by 36
Cited by
Reactive oxygen species and cancer paradox: To promote or to suppress?
Galadari, S., Rahman, A., Pallichankandy, S., & Thayyullathil, F. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.01.004 · Cited by 893
Yu, P., Liu, Z., Wu, D., Chen, M., Lv, W., & Zhao, Y. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2018.04.015 · Cited by 613
Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cells
Yu, J., Li, S., Qi, J., Chen, Z., Wu, Y., Guo, J., Wang, K., Sun, X., & Zheng, J. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1441-4 · Cited by 483
Chen, S.-R., Dai, Y., Zhao, J., Lin, L., Wang, Y., & Wang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00104 · Cited by 326
Impact of Mediterranean diet on metabolic syndrome, cancer and longevity
Di Daniele, N., Noce, A., Vidiri, M. F., Moriconi, E., Marrone, G., Annicchiarico-Petruzzelli, M., D’Urso, G., Tesauro, M., Rovella, V., & De Lorenzo, A. (2017) · Oncotarget · doi:10.18632/oncotarget.13553 · Cited by 324
Metadata
- Authors
- Li, H.-Y., Zhang, J., Sun, L.-L., Li, B.-H., Gao, H.-L., Xie, T., Zhang, N., & Ye, Z.-M.
- Venue
- Cell Death & Disease
- Published
- 2015-01-22
- Volume
- 6
- Issue
- 1
- Pages
- e1604-e1604
- ISSN
- 2041-4889 (ISSN-L)
- OpenAlex
- W2119316865
- Cited by
- 284
- References
- 47
- FWCI
- 57.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.